# Trial of Carfilzomib Plus Melphalan and Prednisone in Elderly Untreated Patients With Multiple Myeloma (CARMYSAP)

> **NCT01279694** · PHASE1,PHASE2 · COMPLETED · sponsor: **Nantes University Hospital** · enrollment: 72 (actual)

## Conditions studied

- Myeloma

## Interventions

- **DRUG:** Carfilzomib
- **DRUG:** Melphalan
- **DRUG:** Prednisone

## Key facts

- **NCT ID:** NCT01279694
- **Lead sponsor:** Nantes University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-10
- **Primary completion:** 2014-02
- **Final completion:** 2014-02
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2016-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01279694

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01279694, "Trial of Carfilzomib Plus Melphalan and Prednisone in Elderly Untreated Patients With Multiple Myeloma (CARMYSAP)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01279694. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*